← Open Payments lookup

LAURA FERGUSON: Open Payments

NPI 1154791028 · COLUMBUS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,729 in 160 payments from 20 companies in 2025. Trend: 2023 $1,321 · 2024 $1,571 · 2025 $2,729

Food & beverage: $2,727Education: $2
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP32$649
GlaxoSmithKline, LLC.32$472
GENZYME CORPORATION14$242
Verona Pharma, Inc.21$235
Grifols USA, LLC11$233
Viatris Specialty LLC11$153
Takeda Pharmaceuticals U.S.A., Inc.8$142
Boehringer Ingelheim Pharmaceuticals, Inc.4$87
Amgen Inc.5$84
Regeneron Healthcare Solutions, Inc.3$69

Products named: DUPIXENT, NUCALA, AIRSUPRA, FASENRA, Ohtuvayre, Prolastin-C Liquid, TRELEGY ELLIPTA, TEZSPIRE.

Industry payments across MS — which companies pay providers there.